Latest News for: naclc
Edit
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC
PR Newswire 06 Dec 2025
LEXINGTON, Mass., Dec ... Results were presented in a late-breaking oral session at the IASLC-ASCO North America Conference on Lung Cancer (NACLC), in Chicago, Illinois ... Additional meeting information can be found on the IASLC-ASCO NACLC website ... 21% ... .
- 1